Literature DB >> 12631669

CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.

T Heliö1, L Halme, M Lappalainen, H Fodstad, P Paavola-Sakki, U Turunen, M Färkkilä, T Krusius, K Kontula.   

Abstract

BACKGROUND: Variants of the caspase activating recruitment domain 15/nucleotide oligomerisation domain 2 (CARD15/NOD2) gene have been associated with susceptibility to Crohn's disease (CD). AIM: Our aim was to evaluate the allele frequencies of the CARD15 variants R702W, G908R, and 1007fs in Finnish inflammatory bowel disease (IBD) patients and to search for possible associations between CARD15 variants and occurrence of familial forms of IBD or complicated forms of CD. PATIENTS AND METHODS: We investigated 198 sporadic CD patients, 46 probands with familial CD, 27 CD probands from mixed IBD families, 99 unrelated patients with ulcerative colitis (UC), and 300 control individuals for the occurrence of the CARD15 gene variants R702W, G908R, and 1007fs.
RESULTS: In CD patients, the allele frequencies for the rare variants of these polymorphisms were 3.3%, 0.6%, and 4.8% (total 8.7%), and the corresponding frequencies in healthy controls were 1.8%, 0%, and 1.7% (total 3.5%) (8.7% v 3.5%; p<0.01). In UC patients allele frequencies were comparable with those in controls. The frequency of the 1007fs polymorphism variant allele was significantly higher among all CD patients than in controls (4.8% v 1.7%; p<0.01) but there was no significant difference in allele frequencies between the CD and UC groups. The 1007fs allele frequency was higher in familial CD than in non-familial cases with CD (10.9% v 3.5%; p<0.01). There were no significant differences in the allele frequencies of the R702W and G908R polymorphisms between CD patients, UC patients, and controls. We found that 15.5% of CD patients, 9.1% of UC patients, and 6.7% of controls carried at least one of the CARD15 variants. In CD patients carrying at least one of the three NOD2 variants, the ileum was affected more often than in non-carrier CD patients (90% v 73%; p<0.05), they had stricturing or penetrating disease more often than non-carriers (88% v 56%; p<0.01), and they had an increased need for bowel surgery.
CONCLUSIONS: The frequency of NOD2 gene variants was lower in genetically homogenous Finns than in other populations. The 1007fs variant was associated with CD. The occurrence of CARD15 variants predicted ileal location as well as stricturing and penetrating forms of CD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631669      PMCID: PMC1773614          DOI: 10.1136/gut.52.4.558

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

Review 1.  Use of population isolates for mapping complex traits.

Authors:  L Peltonen; A Palotie; K Lange
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

2.  International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16.

Authors:  J Cavanaugh
Journal:  Am J Hum Genet       Date:  2001-04-12       Impact factor: 11.025

3.  A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Authors:  C Gasche; J Scholmerich; J Brynskov; G D'Haens; S B Hanauer; E J Irvine; D P Jewell; D Rachmilewitz; D B Sachar; W J Sandborn; L R Sutherland
Journal:  Inflamm Bowel Dis       Date:  2000-02       Impact factor: 5.325

4.  Activation of nuclear factor kappa B inflammatory bowel disease.

Authors:  S Schreiber; S Nikolaus; J Hampe
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

5.  Susceptibility loci in inflammatory bowel disease.

Authors:  M Parkes; J Satsangi; G M Lathrop; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

6.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

7.  Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis.

Authors:  J D Ohmen; H Y Yang; K K Yamamoto; H Y Zhao; Y Ma; L G Bentley; Z Huang; S Gerwehr; S Pressman; C McElree; S Targan; J I Rotter; N Fischel-Ghodsian
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

8.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Authors:  J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

9.  Human Nod1 confers responsiveness to bacterial lipopolysaccharides.

Authors:  N Inohara; Y Ogura; F F Chen; A Muto; G Nuñez
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

10.  A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.

Authors:  K Piippo; H Swan; M Pasternack; H Chapman; K Paavonen; M Viitasalo; L Toivonen; K Kontula
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

View more
  73 in total

1.  Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease.

Authors:  S Koch; T Kucharzik; J Heidemann; A Nusrat; A Luegering
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Choosing Therapy on the Basis of Disease Classifications in Inflammatory Bowel Disease.

Authors:  Maria T. Abreu
Journal:  Curr Treat Options Gastroenterol       Date:  2004-06

3.  Biallelic genotype distributions in papers published in Gut between 1998 and 2003: altered conclusions after recalculating the Hardy-Weinberg equilibrium.

Authors:  B Györffy; I Kocsis; B Vásárhelyi
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 4.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 5.  Genotypes and phenotypes in Crohn's disease: do they help in clinical management?

Authors:  C Gasche; P Grundtner
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

6.  Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.

Authors:  J Halfvarson; A Standaert-Vitse; G Järnerot; B Sendid; T Jouault; L Bodin; A Duhamel; J F Colombel; C Tysk; D Poulain
Journal:  Gut       Date:  2005-04-29       Impact factor: 23.059

7.  DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.

Authors:  C L Noble; E R Nimmo; H Drummond; L Smith; I D R Arnott; J Satsangi
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

8.  CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.

Authors:  B Vander Cruyssen; H Peeters; I E A Hoffman; D Laukens; P Coucke; D Marichal; C Cuvelier; E Remaut; E M Veys; H Mielants; M De Vos; F De Keyser
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

9.  Prediction of Crohn's disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort.

Authors:  Maneesha Bhullar; Finlay Macrae; Gregor Brown; Margie Smith; Ken Sharpe
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

10.  NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease.

Authors:  Devram Sampat Ghorpade; Akhuri Yash Sinha; Sahana Holla; Vikas Singh; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.